Abstract
The GABAA receptor mutation γ2R43Q causes absence epilepsy in humans. Homology modeling suggests that γ2Arg43, γ2Glu178, and β2Arg117 participate in a salt-bridge network linking the γ2 and β2 subunits. Here we show that several mutations at these locations exert similar long-distance effects on other intersubunit interfaces involved in GABA and benzodiazepine binding. These mutations alter GABA-evoked receptor kinetics by slowing deactivation, enhancing desensitization, or both. Kinetic modeling and nonstationary noise analysis for γ2R43Q reveal that these effects are due to slowed GABA unbinding and slowed recovery from desensitization. Both γ2R43Q and β2R117K also speed diazepam dissociation from the receptor’s benzodiazepine binding interface, as assayed by the rate of decay of diazepam-induced potentiation of GABA-evoked currents. These data demonstrate that γ2Arg43 and β2Arg117 similarly regulate the stability of both the GABA and benzodiazepine binding sites at the distant β/α and α/γ intersubunit interfaces, respectively. A simple explanation for these results is that γ2Arg43 and β2Arg117 participate in interactions between the γ2 and β2 subunits, disruptions of which alter the neighboring intersubunit binding sites in a similar fashion. In addition, γ2Arg43 and γ2Glu178 regulate desensitization, probably mediated within the transmembrane domains near the pore. Therefore, mutations at the γ/β intersubunit interface have specific long-distance effects that are propagated widely throughout the GABAA receptor protein.
Footnotes
-
↵
The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
-
This project was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke [Grant NS046378]; the American Epilepsy Society; and the Lennox Trust Fund.
-
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.109.058289
-
ABBREVIATIONS:
- BZD
- benzodiazepine
- DZ
- diazepam
- HEK
- human embryonic kidney
- ANOVA
- analysis of variance.
- Received June 3, 2009.
- Accepted October 21, 2009.
- © 2010 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|